Marijuana companies usher in a new era of collaboration with mainstream players.
Author archives: Omar Sacirbey
Federal Appeals Court Orders DEA to Reconsider if Marijuana Belongs on Schedule 1
The court called DEA “dilatory” for the agency’s notoriously stubborn refusal to objectively consider the health benefits of cannabis.